[go: up one dir, main page]

WO1999048461A3 - Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques - Google Patents

Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques Download PDF

Info

Publication number
WO1999048461A3
WO1999048461A3 PCT/US1999/006494 US9906494W WO9948461A3 WO 1999048461 A3 WO1999048461 A3 WO 1999048461A3 US 9906494 W US9906494 W US 9906494W WO 9948461 A3 WO9948461 A3 WO 9948461A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
aromatic compounds
substituted aromatic
antibiotic resistant
resistant infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/006494
Other languages
English (en)
Other versions
WO1999048461A2 (fr
Inventor
William Y Ellis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of the Army
Original Assignee
United States Department of the Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Department of the Army filed Critical United States Department of the Army
Priority to AU30126/99A priority Critical patent/AU3012699A/en
Priority to CA002325689A priority patent/CA2325689A1/fr
Priority to GB9909183A priority patent/GB2333454B/en
Priority to EP99911497A priority patent/EP1066035A4/fr
Priority to JP2000537515A priority patent/JP2002507557A/ja
Publication of WO1999048461A2 publication Critical patent/WO1999048461A2/fr
Publication of WO1999048461A3 publication Critical patent/WO1999048461A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des composés de formule générale (Y) dans laquelle A représente un hydrocarbure aromatique cyclique et R1 représente un carbone directement lié à un oxygène, et également lié à un azote par l'intermédiaire d'un carbone saturé, l'un au moins parmi R2, R3 et R4 représentant un substituant riche en électrons. Ces agents actifs sont utiles pour traiter des patients souffrant d'infections à organismes gram-positifs, tels que le streptocoque, le staphylocoque, l'anthracis, des bactéries gram-négatives comme celle de l'espèce Neisseria, des levures et des mycobactéries. Ces agents sont efficaces contre les souches dont on connaît la résistance à d'autres agents antimicrobiens.
PCT/US1999/006494 1998-03-26 1999-03-25 Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques Ceased WO1999048461A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU30126/99A AU3012699A (en) 1998-03-26 1999-03-25 Substituted aromatic compounds for treatment of antibiotic resistant infections
CA002325689A CA2325689A1 (fr) 1998-03-26 1999-03-25 Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques
GB9909183A GB2333454B (en) 1998-03-26 1999-03-25 Substituted aromatic compounds for treatment of antibiotic resistant infections
EP99911497A EP1066035A4 (fr) 1998-03-26 1999-03-25 Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques
JP2000537515A JP2002507557A (ja) 1998-03-26 1999-03-25 抗生物質抵抗性感染の処置のための置換芳香族化合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7938398P 1998-03-26 1998-03-26
US60/079,383 1998-03-26

Publications (2)

Publication Number Publication Date
WO1999048461A2 WO1999048461A2 (fr) 1999-09-30
WO1999048461A3 true WO1999048461A3 (fr) 1999-12-16

Family

ID=22150207

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/006494 Ceased WO1999048461A2 (fr) 1998-03-26 1999-03-25 Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques

Country Status (6)

Country Link
EP (1) EP1066035A4 (fr)
JP (1) JP2002507557A (fr)
AU (1) AU3012699A (fr)
CA (1) CA2325689A1 (fr)
GB (1) GB2333454B (fr)
WO (1) WO1999048461A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9241917B2 (en) 2003-03-17 2016-01-26 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1372551T3 (da) 2001-03-08 2009-01-12 Univ Pennsylvania Faciale amphifile polymerer som anti-infektionsmidler
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
DE102010055322A1 (de) * 2010-12-21 2012-06-21 Christian-Albrechts-Universität Zu Kiel Antibakteriell und antimykotisch wirkende Substanzen
EA201992215A1 (ru) 2017-03-20 2020-02-06 Форма Терапьютикс, Инк. Пирролопирроловые композиции в качестве активаторов пируваткиназы (pkr)
EP3852791B1 (fr) 2018-09-19 2024-07-03 Novo Nordisk Health Care AG Activation de la pyruvate kinase r
US10675274B2 (en) 2018-09-19 2020-06-09 Forma Therapeutics, Inc. Activating pyruvate kinase R
WO2021055807A1 (fr) 2019-09-19 2021-03-25 Forma Therapeutics, Inc. Activation de la pyruvate kinase r
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461078A (en) * 1991-04-12 1995-10-24 British Technology Group Limited Anti-cancer compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327022A (en) * 1973-08-16 1982-04-27 Sterling Drug Inc. Heterocyclic alkyl naphthols
IL60530A (en) * 1979-08-16 1984-10-31 American Cyanamid Co Animal feed compositions useful as growth promotors and for reduction of fat in animals,comprising phenylethanolamine derivatives and certain such novel compounds
US5711966A (en) * 1995-08-25 1998-01-27 Woosley; Raymond Method of treating malaria with desbutylhalofantrine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461078A (en) * 1991-04-12 1995-10-24 British Technology Group Limited Anti-cancer compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1066035A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9241917B2 (en) 2003-03-17 2016-01-26 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof

Also Published As

Publication number Publication date
JP2002507557A (ja) 2002-03-12
AU3012699A (en) 1999-10-18
CA2325689A1 (fr) 1999-09-30
WO1999048461A2 (fr) 1999-09-30
GB2333454B (en) 2000-08-09
GB9909183D0 (en) 1999-06-16
GB2333454A (en) 1999-07-28
EP1066035A2 (fr) 2001-01-10
EP1066035A4 (fr) 2001-05-09

Similar Documents

Publication Publication Date Title
CA2350905A1 (fr) Composes de cepheme a base d'imidazo[4,5-b]pyridiniummethyle a large spectre antibacterien
WO2005014585A8 (fr) Quinazolinyl nitrofuranes halogenes utilises comme agents antibacteriens
WO2000034265A3 (fr) Agents antimicrobiens quinoleine-indole, et utilisations et compositions associees
PL319873A1 (en) Antibacterial phenyloxazolydinones
PL409525A1 (pl) Związek 2,3-dihydro-6-nitroimidazo[2,1-b]oksazolowy
WO1999048461A3 (fr) Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques
BR9813248A (pt) Processos para limitar crescimento de um microorganismo, para desinfecção de uma superfìcie e para limitar o crescimento de um vìrus, uma bactéria e/ou um fungo, composição, e, composto contendo metal
CA2160243A1 (fr) Derives de substitution en 36 de rifamycines et leur utilisation comme agents antimicrobiens
HUP0004793A2 (hu) Eljárás alatrofloxacin-mezilát tisztítására és alkalmazására, a vegyületet tartalmazó parenterális készítmények
WO2002002095A3 (fr) Composition et techniques de traitement d'infections bacteriennes
WO2003101382A3 (fr) Composes permettant de traiter l'anthrax et d'inhiber le facteur letal
MXPA06000691A (es) Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables y uso de las mismas.
GB8507528D0 (en) Basis monocarboxyamide derivatives
TR200102234T2 (tr) Psödomonik asit A antibiyotiğinin mikrobiyolojik yöntem ile hazırlanması için işlem
WO2004016632A8 (fr) Derives de lincomycine presentant une activite antibacterienne
DE60006690D1 (de) Antibiotische caprazamycine und verfahren zu deren herstellung
CA2380455A1 (fr) 9a-azalides a activite antibacterienne
WO2004060272A3 (fr) Distribution d'enzymes generant des peroxydes dans le tractus vaginal
WO2004004646A3 (fr) Derives de nocathiacine o-derivatises
WO2003101405A3 (fr) Antibiotiques a base d'amino-glycosides et procedes d'utilisation correspondants
WO2004058182A3 (fr) Utilisation d'enzymes lytiques bacteriophages synergiques pour la prevention et le traitement d'infections bacteriennes
MXPA01010409A (es) Compuestos inhibidores de beta-lactamasa.
Giamarellou et al. In-vitro studies with ceftazidime
WO2001063539A8 (fr) Agents anti-infectieux utiles contre des souches de bacteries resistant a l'action de plusieurs medicaments
MX2007003374A (es) Antibioticos carbociclicos y heterociclicos y uso de los mismos.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA GB JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA GB JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2325689

Country of ref document: CA

Ref country code: CA

Ref document number: 2325689

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 537515

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 30126/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999911497

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999911497

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999911497

Country of ref document: EP